StonvexLoading…
StonvexStonvexStonvexCore line items from RBKB's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $764.00K | $2.98M | $2.24M | $1.50M |
Operating Income | $2.85M | $12.69M | $9.76M | $6.42M |
Net Income | $2.22M | $10.04M | $7.71M | $2.73M |
EPS (Diluted) | $0.20 | $0.92 | $0.70 | $0.46 |
Total Assets | $1.28B | $1.30B | $1.32B | $1.27B |
Total Liabilities | $1.15B | $1.16B | $1.18B | $1.15B |
Cash & Equivalents | $112.90M | $101.99M | $103.47M | $89.62M |
Free Cash Flow OCF − CapEx | $2.88M | $10.89M | $8.47M | $6.44M |
Shares Outstanding | 11.15M | 11.14M | 11.15M | 11.11M |